Jessica Perl

EBS

Jessica Perl serves as SVP, General Counsel, Corp Sec at Emergent BioSolutions Inc. (EBS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$19.3K

Net Position

Net Seller

$19.3K

Companies Traded

EBS

Active Period

Feb 2025 – Feb 2026

2 total trades

Most Recent

Sell EBS

Feb 9, 2026 · $10.1K

Jessica Perl's Insider Trading at Emergent BioSolutions Inc. (EBS)

Buys

0 · $0.00

Sells

2 · $19.3K

Total Shares Bought

Total Shares Sold

1,836

EBS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 9, 2026	Sell	918	$11.03	$10.1K	0
Feb 9, 2025	Sell	918	$10.00	$9.2K	0

Related Insiders

William Hartzel

SVP, Bioservices

EBSSell · Feb 6, 2026

Coleen Glessner

EVP, Quality & Ethics, and CPL

EBSSell · Feb 6, 2026

Paul Anthony Williams

SVP, Products Business

EBSSell · Feb 6, 2026

LINDAHL RICHARD S

EVP, Chief Financial Officer

EBSSell · Feb 6, 2026

Simon C Lowry

SVP, R&D, CMO

EBSSell · Dec 14, 2025

Ronald Richard

Director

EBSSell · Dec 5, 2025

Donald W DeGolyer

Director

EBSSell · Nov 10, 2025

Sujata Tyagi Dayal

Director

EBSSell · Nov 7, 2025

Explore More Insider Trading Data

EBS Insider Trading Activity

View all insider trades at Emergent BioSolutions Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity